Eucomed: Co-ordination, not centralisation, is key to sustainable EU
This article was originally published in RAJ Devices
What healthcare products will be available to which patients, at what speed and at what level of control? And can Europe afford what it really wants? These are the fundamental questions testing Europe's regulatory experts. John Wilkinson and John Brennan of European medtech industry association Eucomed believe co-ordination among competent authorities is the answer to creating a sustainable system that will last for the next 15-20 years. They explained why to Amanda Maxwell.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies